Neurogene Market Cap

Neurogene has a market cap or net worth of $581.91 million as of July 26, 2024. Its market cap has increased by 1,516.41% in one year.

Market Cap

581.91M

Enterprise Value

427.73M

1-Year Change

1,516.41%

Ranking

#2943

Market Cap Chart

Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $581.91M, an increase of 410.00%. That is a compound annual growth rate of 16.97%.

Market Cap History

Date	Market Cap	% Change
Jul 25, 2024	554.30M	1,118.24%
Dec 29, 2023	45.50M	109.68%
Dec 30, 2022	21.70M	-89.39%
Dec 31, 2021	204.50M	-65.38%
Dec 31, 2020	590.70M	25.07%
Dec 31, 2019	472.30M	829.72%
Dec 31, 2018	50.80M	-81.59%
Dec 29, 2017	275.90M	-28.65%
Dec 30, 2016	386.70M	80.03%
Dec 31, 2015	214.80M	167.83%
Dec 31, 2014	80.20M	-29.71%
Mar 7, 2014	114.10M	-

View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eliem Therapeutics	574.35M
Cassava Sciences	567.75M
Canopy Growth	562.99M
Terns Pharmaceuticals	562.04M
OmniAb	555.18M
Cross Country Healthcare	551.86M
Anavex Life Sciences	549.32M
Castle Biosciences	545.66M

Market Cap Rankings